Insud Pharma

Madrid, Spain Founded: 1977 • Age: 49 yrs
Finished formulations, APIs, and monoclonal antibodies are developed and manufactured.

About Insud Pharma

Insud Pharma is a Healthcare company based in Madrid (Spain) founded in 1977 by Hugo Sigman and Silvia Gold. Finished formulations, APIs, and monoclonal antibodies are developed and manufactured. It operates on a Direct-to-Consumer (D2C) model. Insud Pharma has completed 2 acquisitions, including Agile Therapeutics and Viatris. Its website insudpharma.com draws about 15 thousand monthly visits. Insud Pharma offers products and services including Pharmaceutical Solutions. Its focus areas include Pharmaceuticals and Drug Manufacturing. Its legal entity is Insud Pharma, S.L.

Company details

Insud Pharma is involved in the development and manufacturing of pharmaceutical solutions aimed at improving global health. The company operates across various sectors within healthcare, focusing on innovative drug production. With a presence in over 50 countries, numerous industrial plants, and RD centers, comprehensive health solutions are provided to meet diverse needs. Sustainability and ethical practices are integrated into operations to ensure responsible growth.

  • Headquarters Madrid, Spain
  • Founders Hugo Sigman, Silvia Gold
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website insudpharma.com
  • Social LinkedIn X Instagram
  • Legal Name Insud Pharma, S.L.
Key Metrics

Products & Services of Insud Pharma

Insud Pharma offers a comprehensive portfolio of products and services, including Pharmaceutical Solutions.

Pharmaceutical Solutions
Healthcare

Pharmaceutical solutions are developed for global health needs.

Funding Insights of Insud Pharma

  • Total Rounds 1
  • Last Round Grant β€” $2.7M
  • First Round $2.7M

    (Nov 2024)

  • Investors Count 1

All 1 funding rounds of Insud Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2024$2.7MGrant––
Valuation history

1 investors in total: 1 institutional.

Investors in Insud Pharma

Insud Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Gates Foundation.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Charitable foundation investments on poverty reduction and healthcare
2000gatesfoundation.orgSeattle, United States
Premium access

Investor details for Insud Pharma

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Insud Pharma

34 people are tracked at Insud Pharma (14 in leadership, 20 in team).

NameRoleGroup
Hugo Sigman
Co-FounderLeadership
Silvia Gold
Co-FounderLeadership
Lucas Sigman
CEOLeadership
Baburao Walunj
Head Of Quality ControlLeadership
Mirian Cuenca
Global Regulatory Affairs DirectorLeadership
Ariel Plaza
Director Corporativo Global De EHSLeadership
Rajesh Aher
Head Of Department EHSLeadership
Carlos Romero-Camacho
Chief People & Corporate Affairs OfficerLeadership
Ed Carey
VP & Global Head, Quality & ComplianceLeadership
Jørgen Matz
Head, Global Clinical Quality & PharmacovigilanceLeadership
Nihal Hamdalla
Director Of Supply, Regulatory, Quality, Pv. MEA RegionLeadership
Zuleyha Aygun
Quality Systems & Compliance DirectorLeadership
Antonella Volpe
Global API Quality And Regulatory DirectorLeadership
Emilio J. Pericet Grande
Chief Technology OfficerLeadership
Vasu Morla
Agm, Global CQATeam
Isabel Perdiguero Osuna
Quality Assurance SupervisorTeam
Erica Heringer
Project And Quality ManagerTeam
Carmen Cortina
Patient Safety Physician And Risk Mitigation ManagerTeam
Lucía López Castro
Regulatory And Quality API TechnicianTeam
Cecilia Morán Seijas
Quality Assurance Supervisor, Validations - Deputy QPTeam

14 more people are available in the full profile.

Premium access

Complete people profiles for Insud Pharma

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Insud Pharma

Insud Pharma has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Agile Therapeutics and Viatris.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Therapeutics for women's healthcare are developed and offered.
agiletherapeutics.comPrinceton, United States1997Aug 2024β€’β€’β€’β€’
Branded pharmaceuticals are developed and commercialized by Viatris internationally.
viatris.comFrankfurt, Germany1998Mar 2024β€’β€’β€’β€’
Premium access

Complete acquisition details for Insud Pharma

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Insud Pharma

4 dated milestones of Insud Pharma across 47 years, from founding to its latest funding, stage changes and deals.

  1. Founded Insud Pharma is founded.
  2. Acquisition Acquires Viatris.
  3. Acquisition Acquires Agile Therapeutics.
  4. Funding First funding round of $2.7M.

Web traffic of Insud Pharma

The website of Insud Pharma (insudpharma.com) receives about 14.6K visits a month and ranks #1,472,055 among all websites worldwide, #1,928 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    14.6K

    ▼ 5.9% vs previous month

  • Unique visitors
    6.8K

    per month

  • Global rank
    #1,472,055

    among all websites

  • Category rank
    #1,928

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Insud Pharma. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
concordbiotech.com
100%
3.7K#4,215,278View details
swisspharma.in
96%
1.3K#10,147,211View details
alembicpharmaceuticals.com
90%
23K#2,083,600View details
nilrisepharma.com
88%
#3,419,796View details
cadilapharma.com
87%
18.5K#1,452,788View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 13 similar websites and full traffic analytics for Insud Pharma

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 13 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Insud Pharma

Premium access

Complete news archive for Insud Pharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Insud Pharma

Insud Pharma was founded in 1977 and raised its 1st funding round 47 years after it was founded.

Insud Pharma is headquartered in Madrid, Spain. It is registered at Madrid, Madrid, Spain.

Insud Pharma is involved in the development and manufacturing of pharmaceutical solutions aimed at improving global health. The company operates across various sectors within healthcare, focusing on innovative drug production. With a presence in over 50 countries, numerous industrial plants, and RD centers, comprehensive health solutions are provided to meet diverse needs. Sustainability and ethical practices are integrated into operations to ensure responsible growth.

Insud Pharma offers Pharmaceutical Solutions.

Insud Pharma has made 2 acquisitions, including Agile Therapeutics, and Viatris.

Insud Pharma has 1 investor. Key investors include Gates Foundation.

Insud Pharma operates through Insud Pharma, S.L..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available